• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT CRM S.R.L. PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT CRM S.R.L. PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION Back to Search Results
Model Number PLATINIUM SONR CRT-D 1811
Device Problems Failure to Capture (1081); High impedance (1291)
Patient Problems No Information (3190); Insufficient Information (4580)
Event Date 01/02/2021
Event Type  malfunction  
Manufacturer Narrative
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by microport crm that was cleared or approved by fda for marketing in the united states.
 
Event Description
The crt-d was implanted on (b)(6) 2020 and connected to the associated left ventricular lead, which was implanted on (b)(6) 2013.The patient is pacing-dependent.Reportedly, during a remote follow-up performed on (b)(6) 2021, it was observed that left ventricular lead impedance measurements abruptly increased and were saturated at 3000 ohms.A follow-up was then performed on (b)(6) 2021, left ventricular lead impedance measurement saturated at 3000 ohms was observed.In addition, loss of ventricular capture in lv ring ¿ rv coil configuration was noticed.The left ventricular pacing configuration was reprogrammed to lv tip ¿ rv coil.The ventricular capture threshold was elevated but proper capture was confirmed.Left ventricular lead impedance measurement was within normal range.It was decided to keep this configuration programmed and to follow closely the patient via remote monitoring in case of re-occurrence of lead issues.Preliminary analysis revealed that abnormal left ventricular lead impedance measurements most probably resulted from a left ventricular lead issue.
 
Manufacturer Narrative
Please refer to the attached analysis report.
 
Event Description
The crt-d was implanted on (b)(6) 2020 and connected to the associated left ventricular lead, which was implanted on (b)(6) 2013.The patient is pacing-dependent.Reportedly, during a remote follow-up performed on (b)(6) 2021, it was observed that left ventricular lead impedance measurements abruptly increased and were saturated at 3000 ohms.A follow-up was then performed on (b)(6) 2021, left ventricular lead impedance measurement saturated at 3000 ohms was observed.In addition, loss of ventricular capture in lv ring - rv coil configuration was noticed.The left ventricular pacing configuration was reprogrammed to lv tip - rv coil.The ventricular capture threshold was elevated but proper capture was confirmed.Left ventricular lead impedance measurement was within normal range.It was decided to keep this configuration programmed and to follow closely the patient via remote monitoring in case of re-occurrence of lead issues.Preliminary analysis revealed that abnormal left ventricular lead impedance measurements most probably resulted from a left ventricular lead issue.
 
Event Description
The crt-d was implanted on (b)(6) 2020 and connected to the associated left ventricular lead, which was implanted on (b)(6) 2013.The patient is pacing-dependent.Reportedly, during a remote follow-up performed on (b)(6) 2021, it was observed that left ventricular lead impedance measurements abruptly increased and were saturated at 3000 ohms.A follow-up was then performed on (b)(6) 2021, left ventricular lead impedance measurement saturated at 3000 ohms was observed.In addition, loss of ventricular capture in lv ring - rv coil configuration was noticed.The left ventricular pacing configuration was reprogrammed to lv tip - rv coil.The ventricular capture threshold was elevated but proper capture was confirmed.Left ventricular lead impedance measurement was within normal range.It was decided to keep this configuration programmed and to follow closely the patient via remote monitoring in case of re-occurrence of lead issues.Preliminary analysis revealed that abnormal left ventricular lead impedance measurements most probably resulted from a left ventricular lead issue.
 
Manufacturer Narrative
D3 - g1 corrected.Microport crm was notified on (b)(6) 2021 that a re-intervention was performed on the same day to replace the associated left ventricular lead, since its impedance value was higher than 4000 ohms.The left ventricular lead was abandoned in patient's body.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLATINIUM
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION
Manufacturer (Section D)
MICROPORT CRM S.R.L.
via crescentino s.n.
.
saluggia (vc), 13040
IT  13040
MDR Report Key11273904
MDR Text Key233742413
Report Number1000165971-2021-00257
Device Sequence Number1
Product Code NIK
UDI-Device Identifier08031527014388
UDI-Public(01)08031527014388(11)181205(17)200705
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 08/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/05/2020
Device Model NumberPLATINIUM SONR CRT-D 1811
Device Catalogue NumberPLATINIUM SONR CRT-D 1811
Device Lot NumberS0347
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/08/2021
Date Manufacturer Received08/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-